Gabriel Baertschi
Director/Board Member at DKSH HOLDING AG
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Eric-Paul Pâques | M | 70 |
Grunenthal Italia Srl
Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi.
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | 23 years |
Andreas Willy Keller | M | 79 | 22 years | |
Laurent Zbinden | M | - |
MedXCell SA
MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | 8 years |
Marco Gadola | M | 61 | 5 years | |
Laurent Sigismondi | M | 48 | 9 years | |
Adrian Thomas Keller | M | 73 | 22 years | |
Wolfgang Baier | M | 50 | 5 years | |
Ido Wallach | M | 49 | 5 years | |
Eunice Zehnder-Lai | F | 57 | 6 years | |
Stefan Butz | M | 56 | 7 years | |
Annette Koehler | M | 57 | 6 years | |
Jack Clemons | M | 58 | 5 years | |
Hans Tanner | M | 72 | 13 years | |
Till Leisner | M | 42 | - | |
Martin Zügel | M | 62 |
Grunenthal Italia Srl
Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi.
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | - |
Hanno Elbraechter | M | 44 | 10 years | |
John McMannis | M | - |
MedXCell SA
MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | - |
Thomas Ludwig | M | 75 |
Grunenthal Italia Srl
Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | - |
Pär Johansson | M | 58 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | - |
Antoine Mangin | M | 48 | 4 years | |
Andrew Galazka | M | 69 |
MedXCell SA
MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | - |
Franz Wynands | M | 65 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | - |
Petra Danielsohn-Weil | M | 64 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | 5 years |
Gotthard Kleine | M | 69 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | - |
Edouard P. Croufer | M | 77 |
Grunenthal Italia Srl
Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | - |
Bijay Singh | M | 60 | 9 years | |
Anh Nguyen | M | - |
MedXCell SA
MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | - |
Stephen John Ferraby | M | 60 | 9 years | |
Sam Oh | M | 58 | 3 years | |
Wilhelm Moll | M | 74 |
Grunenthal Italia Srl
Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | - |
Jean-Jacques De Dardel | M | - |
MedXCell SA
MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Heinz-Gerd Suelmann | M | 58 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | 10 years |
Dieter Peters | M | 68 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | 16 years |
Oscar Ferenczi | M | 60 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | 5 years |
Sascha Becker | M | 54 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | 4 years |
Dmitry Zamoryakhin | M | 44 |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany. | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Switzerland | 22 | 61.11% |
Germany | 11 | 30.56% |
Italy | 5 | 13.89% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gabriel Baertschi
- Personal Network